Emergent BioSolutions (EBS) Tops Q3 View; Raises Guidance
Tweet Send to a Friend
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $0.10, 13 cents better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
